| Product Code: ETC8291182 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Transarterial Chemoembolization (TACE) Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 Mexico Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of liver cancer in Mexico |
4.2.2 Growing adoption of minimally invasive procedures for cancer treatment |
4.2.3 Technological advancements in transarterial chemoembolization (TACE) procedures |
4.3 Market Restraints |
4.3.1 High cost associated with TACE treatment |
4.3.2 Limited availability of skilled healthcare professionals specialized in performing TACE procedures |
4.3.3 Stringent regulatory requirements for TACE equipment and materials |
5 Mexico Transarterial Chemoembolization (TACE) Market Trends |
6 Mexico Transarterial Chemoembolization (TACE) Market, By Types |
6.1 Mexico Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 Mexico Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 Mexico Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 Mexico Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 Mexico Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 Mexico Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 Mexico Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Patient survival rates post-TACE treatment |
8.2 Number of TACE procedures performed annually in Mexico |
8.3 Adoption rate of TACE as a primary treatment option for liver cancer patients |
9 Mexico Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 Mexico Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Mexico Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Mexico Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 Mexico Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 Mexico Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here